title: Regulatory agencies, pharmaceutical information and the Internet: a European perspective.
abstract: The Internet facilitates access to health information and can therefore support the effectiveness of healthcare provision and empower patients in healthcare decisions. In the field of pharmaceutical therapy the electronic provision of information can improve compliance and strengthen the general understanding of pharmaceutical risks and benefits. Current political developments in Europe encourage a stronger role of the pharmaceutical industry in this regard. In light of potential conflicts inherent to the private provision of information and given their public health mandate, regulatory bodies in the pharmaceutical sector may represent an important alternative source of information. The explorative analysis in this paper reviews the websites of European pharmaceutical regulatory agencies regarding the usability and provision of information from a Layman's perspective. It is found that while the majority of agencies do provide product-related information, the usability of websites from the lay perspective is subject to variation. The reluctant position of agencies can be attributed to sectoral path dependencies, the regulatory approach and a lack of regulatory resources.
authors.affiliation: Max-Weber-Institute of Sociology, University of Heidelberg, Germany. R.Bauschke@uni-heidelberg.de
authors.forename: Rafael
authors.initials: R
authors.lastname: Bauschke
mesh_terms: D022126:Access to Information; D016907:Adverse Drug Reaction Reporting Systems; D003257:Consumer Product Safety; D004345:Drug Industry; D005062:European Union; D006307:Health Systems Agencies; D006801:Humans; D020407:Internet; D004364:Pharmaceutical Preparations; D011358:Product Surveillance, Postmarketing
chemical_list: D004364:Pharmaceutical Preparations